Sagimet Biosciences Inc. (SGMT) has 17 open-market insider trades by 7 insiders since 2023. Over the last six months insiders net sold $579K. The most active filer is David Happel, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| David Happel | CEOPres | — | 6 | $1.9M | 2026-07-20 |
| Beth C. Seidenberg | Dir | — | 1 | $750K | 2023-07-18 |
| Patrick J. Kerins | 10% Owner | — | 1 | $491K | 2024-01-29 |
| Elizabeth Rozek | CLO | — | 4 | $327K | 2026-07-20 |
| Eduardo Bruno Martins | — | — | 3 | $197K | 2026-02-19 |
| George Kemble | Dir | — | 1 | $44K | 2026-08-14 |
| Thierry Chauche | CFO | — | 1 | $7K | 2026-02-19 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| George Kemble | Director | Sell | $3.6M | 2026-08-14 |
| George Kemble | Director | Sell | $201K | 2026-08-11 |
| George Kemble | Director | Sell | $141K | 2026-07-20 |
| Elizabeth Rozek | CLO | Sell | $82K | 2026-07-20 |
| David Happel | CEO & President | Sell | $497K | 2026-07-20 |
| Elizabeth Rozek | Chief Legal & Admin. Officer | Sell | $14K |
Companies that share insiders with SGMT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-02-10 |
| Thierry Chauche | CFO | Sell | $7K | 2026-02-10 |
| David Happel | President | Sell | $65K | 2026-02-10 |
| Eduardo Bruno Martins | Chief Medical Officer | Sell | $20K | 2026-02-10 |
| George Kemble | Chairman | Sell | $580K | 2025-11-20 |
| David Happel | CEO & President | Sell | $1.2M | 2025-07-21 |
| Elizabeth Rozek | CLO & CCO | Sell | $197K | 2025-07-21 |
| Eduardo Bruno Martins | — | Sell | $151K | 2025-07-21 |
| George Kemble | Chairman | Sell | $150K | 2024-07-23 |
| Elizabeth Rozek | General Counsel and CCO | Sell | $34K | 2024-07-19 |